Literature DB >> 11892265

Growth hormone in glucocorticoid-induced osteoporosis.

F Manelli1, R Carpinteri, S Bossoni, A Burattin, S Bonadonna, E Agabiti Rosei, A Giustina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11892265     DOI： 10.1159/000061083

Source DB:  PubMed          Journal:  Front Horm Res        ISSN： 0301-3073            Impact factor:   2.606


× No keyword cloud information.
  9 in total

Review 1.  Current guidelines for adult GH replacement.

Authors:  Mauro Doga; Stefania Bonadonna; Monica Gola; Sebastiano Bruno Solerte; Giovanni Amato; Carlo Carella; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

2.  Treatment of glucocorticoid-induced osteoporsis.

Authors:  Gherardo Mazziotti; Andrea Giustina; Ernesto Canalis; John P Bilezikian
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-02       Impact factor: 5.346

Review 3.  Cushing's syndrome and bone.

Authors:  Tatiana Mancini; Mauro Doga; Gherardo Mazziotti; Andrea Giustina
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 4.  Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.

Authors:  Pojchong Chotiyarnwong; Eugene V McCloskey
Journal:  Nat Rev Endocrinol       Date:  2020-04-14       Impact factor: 43.330

Review 5.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

6.  Treatment of Cushing disease: overview and recent findings.

Authors:  Tatiana Mancini; Teresa Porcelli; Andrea Giustina
Journal:  Ther Clin Risk Manag       Date:  2010-10-21       Impact factor: 2.423

Review 7.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Authors:  E Canalis; G Mazziotti; A Giustina; J P Bilezikian
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

Review 8.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

9.  Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.

Authors:  Afroze Abbas; Marian Schini; Gemma Ainsworth; Sarah R Brown; Jamie Oughton; Rachel K Crowley; Mark S Cooper; Rebecca J Fairclough; Richard Eastell; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.